¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"extensor process disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • insect-borne disease
    °ïÃæ¸Å°³º´
  • integumentary disease
    ¿ÜÇÇÁúȯ
  • intercurrent disease
    º´¹ßÁúȯ
  • International Classification of Disease
    ±¹Á¦Áúº´ºÐ·ù
  • interstitial disease
    »çÀÌÁúº´, °£ÁúÁúȯ
  • interstitial lung disease
    »çÀÌÁúÆóÁúȯ, °£Áú¼ºÆóÁúȯ
  • intestinal disease
    ÀåÁúȯ, âÀÚº´
  • jumping disease
    µµ¾àº´
  • kinky hair disease
    ¾ûŲ¸Ó¸®Ä«¶ôº´
  • Kawasaki disease
    °¡¿Í»çŰº´
  • kidney disease
    ÄáÆÏº´, ½ÅÀ庴
  • Kikuchi disease
    ±âÄíÄ¡º´
  • law of prophylaxis for infectious disease
    Àü¿°º´¿¹¹æ¹ý
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´
  • Legg-Calve-Perthes disease
    ·¹±×-Ä®º£-Æä¸£Å×½ºº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • jumping disease
    µµ¾àº´
  • kidney disease
    ÄáÆÏº´, ½ÅÀ庴
  • legal communicable disease
    ¹ýÁ¤Àü¿°º´
  • lipid storage disease
    ÁöÁúÃàÀûº´
  • liver disease
    °£º´, °£Áúȯ
  • luetic heart disease
    ¸Åµ¶½ÉÀ庴
  • lung disease
    Æóº´
  • lysosomal storage disease
    ¸®¼Ò¼ØÃàÀûº´, ¿ëÇØ¼ÒüÃàÀûº´
  • malabsorption disease
    Èí¼öÀå¾Öº´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    (¢¡osteopetrosis) »À´ë¸®¼®Áõ, °ñÈ­¼®Áõ
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • medullary cystic disease
    ¼ÓÁú³¶¼ºº´, ¼ÓÁúÁÖ¸Ó´ÏÄáÆÏº´
  • metabolic disease
    ´ë»çº´, ´ë»çÁúȯ
  • metazoan disease
    ÈÄ»ýµ¿¹°°¨¿°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • acquired heart disease =AHD
    ÈÄõ¼º ½ÉÁúȯ(¡­ãýòðü´).
  • acute demyelinating disease
    ±Þ¼º Å»¼öÃʼº Áúȯ(¡­÷­âÐõ¦àõòðü´).
  • acute febrile neutrophilic dermatosis ; Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ.
  • acute febrile neutrophilic dermatosis = Sweet disease
    ±Þ¼º À¯¿­ È£Áß±¸¼º ÇǺÎÁõ
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute infectious disease =AID
    ±Þ¼º Àü¿°º´(¡­îîæøÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • acute respiratory disease =ARD
    ±Þ¼º È£Èí±âº´(¡­û¼ýåÐïÜ»).
  • addisons disease
    ¾Öµð½¼º´<<ºÎ½Å±â´ÉºÎÀü>>
  • addisons disease
    ¾Öµð½¼º´(¡­Ü»)
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • adjuvant disease
    ¾ÖÁÖ¹øÆ®º´.
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • african sleeping disease
    ¾ÆÇÁ¸®Ä« ¼ö¸éº´(¡­â²ØùÜ»)
  • air borne disease
    °ø±â¸Å°³Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • palatine process [secondary palate]
    ÀÔõÀåµ¹±â (ÀÌÂ÷ÀÔõÀå)
  • palatine process ³ª processus palatinus
    ±¸°³µ¹±â(Ï¢ËÏÔÍÑÃ).
  • papillary process
    À¯µÎµ¹±â
  • papillary process ³ª processus papillaris
    À¯µÎµ¹±â(êáÔéÔÍÑÃ).
  • paramastoid process
    (²ÀÁö¿·µ¹±â)
  • paramastoid process ³ª processus paramastoideu
    À¯µ¹¹æµ¹±â(êáÔÍÛ±ÔÍÑÃ).
  • peripheral dendritic process
    ¸»Ãʰ¡Áöµ¹±â¼º µ¹±â, ¸»Ãʼö»óµ¹±â¼º µ¹±â(¡­ â§ßÒÔÍÑÃàõÔÍÑÃ).
  • phalangeal process
    ¼Õ°¡¶ôµ¹±â
  • polyploid process
  • polyploid process
  • polypoid process
    ¹ö¼¸µ¹±â
  • posterior clinoid process
    µÚħ´ëµ¹±â
  • posterior clinoid process ³ª processus clinoideus p.
    µÚħ»óµ¹±â, ÈĻ󵹱â(ý­ßÉÔÍÑÃ).
  • posterior clinoid process ³ª processus clinoideus p.
    µÚħ»óµ¹±â, ÈĻ󵹱â(ý­ßÉÔÍÑÃ).
  • posterior process of septal nasal cartilage
    µÚµ¹±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
CSPINE corticosteroid use, seropositive RA, peripheral joint destruction, involvement of cervical nerves, n...
DILD diffuse infiltrative lung disease; diffuse interstitial lung disease
DPD Department of Public Dispensary; depression pure disease; desoxypyridoxine; diffuse pulmonary diseas...
GSD genetically significant dose; Gerstmann-Straussler disease; glutathione synthetase deficiency; glyco...
HLD hepatolenticular degeneration; herniated lumbar disk; Hippel-Lindau disease; hypersensitivity lung d...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
COLD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Pulmonary Disease
CRDQ Chronic Respiratory Disease Questionnaire
CRQ Chronic Respiratory Disease Questionnaire
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • motor neurone disease
    ¿îµ¿ ½Å°æ¿ø¼º Áúȯ
  • motor system disease
    ¿îµ¿°è Àå¾Ö
  • mountain disease
    °í»êº´, »ê¾Çº´, »ê¸Ö¹Ì
    Àú»ê¼ÒÁõÀ» ÀÏÀ¸Å°±â¿¡´Â ÃæºÐÇÑ °í¼Ò¿¡ ³ëÃâµÊÀ¸·Î½á ÀϾ´Â ÁõÈıºÀ¸·Î¼­, °¨¼ÒµÈ ´ë±â¾Ð°ú ÀÌ¿¡ µû¸£´Â µ¿¸ÆÇ÷ÀÇ »ê¼Ò ÇÔ·® ÀúÇÏÀÇ °á°ú·Î ÀϾ´Ù. ±Þ¼ºÇü
  • Moyamoya disease
    ¸ð¾ß¸ð¾ß º´
    1. ³»°æ µ¿¸Æ ¸»´ÜºÎ¿¡ ÇùÂø, Æó»öÀÇ ¾ç»óÀÌ ³ªÅ¸³ª´Â Áúȯ.Àª¸®½º µ¿¸Æ·û Æó»öÁõ, ³úÀúºÎ ÀÌ»ó Ç÷°ü¸ÁÁõÀ̶ó°íµµ ÇÑ´Ù. µ¹¹ß¼º ³ú Ç÷°ü ºÎÀüÁõ¿¡¼­ º¼ ¼ö Àִµ¥ ³ú ÀúºÎÀÇ Á¤»ó Ç÷°ü ´ë½Å¿¡ ¼Òµ¿¸ÆÀÇ Èñ¹ÌÇÑ ±×¹° ¸ð¾ç
  • mucosal disease
    Á¡¸· º´
  • Mukulicz disease
    ¹«Å¬¸®Âê º´
    ´©¼±°ú Ÿ¾×¼±ÀÌ ÆíÃø¼º ¶Ç´Â ´ëμºÀ¸·Î Á¾Ã¢ÀÌ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î, ÀÌÇϼ±¿¡¼­ ÁÖ·Î ¹ß»ýµÇ³ª ¸¹Àº ¼ÒŸ¾×¼±µéµµ Á¾Ã¢ÀÌ ³ªÅ¸³ª¸ç ¾Æ¹«·± Áõ»óÀÌ ¾øÀÌ ¼ö°³¿ù ¶Ç´Â ¼ö³â°£ Áö¼ÓµÇ±âµµ ÇÑ´Ù. Ÿ¾×¼± Á¶Á÷¿¡ ¸²ÇÁ±¸ÀÇ Ä§À±À¸·Î Ÿ¾×¼± ½ÇÁú Á¶Á÷ÀÌ À§ÃàµÇ°í ¼Ò½ÇµÇ¸ç µµ°ü »óÇÇÀÇ Áõ½ÄÀ¸·Î °ü°­ÀÌ Çù¼ÒÇØÁö°í µµ°ü »óÇÇ¿Í ±Ù»óÇÇ ¼¼Æ÷ÀÇ Áõ½ÄÀ¸·Î Ç¥ÇDZ٠»óÇǷθ¦ Çü¼ºÇÑ´Ù.
  • mushroom picker's disease
    ¹ö¼¸ ÀÛ¾÷ÀÚ º´
    ³óºÎ Æó¿Í À¯»çÇÑ ¾Ë·¯Áö¼º È£Èí°è ÁúȯÀ¸·Î¼­ ¹ÐÆóµÈ Àå¼Ò¿¡¼­ ¹ö¼¸ »ýÀ°¿ëÀÇ ½âÀº Åðºñ¸¦ Ãë±ÞÇÏ´Â »ç¶÷µé, ƯÈ÷ ¼öÈ® ÈÄ °ÇÁ¶¹°À» Ãë±ÞÇÏ´Â »ç¶÷µé¿¡°Ô¼­ ¹ßº´ÇÑ´Ù.
  • neoplastic disease
    ½Å»ý¹° Áúȯ, Á¾¾ç¼º Áúȯ, ½Å»ý¹°¼º Áúȯ
  • neuronal storage disease
    ½Å°æ ÃàÀûÁõ
  • nevoid disease
    ¸ð¹Ý¾çÁõ
  • Newcastle disease
    ´ºÄ¹½½ º´
    °¡±Ý·ù¸¦ Æ÷ÇÔÇÑ Á¶·ùÀÇ ¹ÙÀÌ·¯½º º´À¸·Î¼­ È£Èí±â ¹× À§Àå ¶Ç´Â Æó·Å ¹× ³ú¿° Áõ»óÀÌ Æ¯Â¡ÀÌ´Ù. ¿µ±¹ÀÇ ´ºÄ¹½½ ºÎ±Ù¿¡¼­ ÃÖÃÊ·Î ¹ß°ßµÇ¾úÀ¸¸ç °¨¿°µÈ Á¶·ù¿ÍÀÇ Á¢ÃËÀ¸·Î »ç¶÷¿¡°Ô ¸Å°³µÈ´Ù.
  • Niemann disease
    ´Ï¸¸ÇÈ Áúȯ
    »ýÈÄ ¸î °³¿ùÂë ÇØ¼­ ¹ßº´Çϴµ¥, ½ÉÇÑ °£ºñ Á¾Ã¢, ºÎÁ¾, º¹¼ö, ÇǺÎÀÇ È²»öÁ¶ µîÀÇ Áõ»óÀ» º¼ ¼ö ÀÖ°í, Á¶Á÷ÇÐÀûÀ¸·Î´Â ¸Á³»°è ¼¼Æ÷°¡ ´Ù·®ÀÇ ¸®Æ÷À̵带 ޽ÄÇÏ¿© ´Ï¸¸-ÇÇÅ© ¼¼Æ÷·Î º¯È­ÇØ °£´Ù.
  • Norrie's disease ¸Á¸· ±âÇü¿¡ ÀÇÇÑ ¾çÂÊ ´«ÀÇ ½Ç¸í, Á¤½Å ¹ß´Þ Áö¿¬, ³­Ã»ÀÌ ³ªÅ¸³ª´Â À¯Àü¼º ÁúȯÀ¸·Î¼­ ¹Ý¼º À¯ÀüÀ¸·Î Àü´ÞµÈ´Ù.

    North America

    ºÏ¹Ì
  • notifiable disease
    ½Å°í ´ë»ó º´
    Àü¿°¼º, ÁßÁõµµ ¹× ºóµµ ¶§¹®¿¡ Áß¾Ó, ÁÖ ¶Ç´Â Áö¹æ °üû¿¡ ¹ß»ý º¸°í¸¦ ¿äÇÏ´Â Áúȯ.
  • obliterative arterial disease
    Æó»ö¼º µ¿¸Æ Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
alexander disease <radiology> Dysmyelinating disease, rare, sporadic, usually presents in 1st year, gradual enlargement of head (Differential diagnosis: Canavan disease), retardation, convulsion, spasticity CT findings: decreased density of white matter, frontal lobe predominance, with or without dilated lateral ventricles Diagnosis: brain biopsy
(12 Dec 1998)
Alexander's disease A rare, fatal central nervous system degenerative disease of infants, characterised by psychomotor retardation, seizures, and paralysis; megaloencephaly is associated with widespread leukodystrophic changes, especially in the frontal lobes.
(05 Mar 2000)
alkali disease A term applied to various animal poisonings of plant and mineral origin in arid regions under the belief that they were caused by the ingestion of alkaline waters; e.g., botulism of wild ducks, caused by feeding on decayed vegetation in nearly dried-up lakes.
(05 Mar 2000)
Almeida's disease <microbiology> A chronic fungal infection caused by Paracoccidioides brasiliensis.
It is characterised by primary pulmonary lesions with dissemination to many visceral organs.
Common findings include ulcerative granuloma lesions to the buccal mucosa (inner lining of the cheek) and nasal mucosa that extend to the surrounding skin. Generalised lymphangitis is also typical.
More commonly seen in South America and the tropics.
(15 Nov 1997)
Alpers disease Familial progressive spastic paresis of extremities with progressive mental deterioration, with development of seizures, blindness and deafness, beginning during the first year of life, and with destruction and disorganization of nerve cells of the cerebral cortex.
Synonym: Alpers disease, Christensen-Krabbe disease, progressive cerebral poliodystrophy.
(05 Mar 2000)
alpha chain disease A vague or indefinite term; could be used for alpha-heavy-chain disease (a lymphoplasma cell proliferative disease usually seen in Mediterranean men, characterised by intestinal involvement with steatorrhoea, often progressive with fatal outcome) or a thalassaemia (a genetic abnormality in the alpha globin chain of haemoglobin).
(05 Mar 2000)
altitude disease A condition that results from prolonged exposure to high altitude.
Symptoms include a continuous dry cough, shortness of breath, poor exercise tolerance, dizziness, headache, sleep difficulty, anorexia, confusion, fatigue and a rapid pulse.
Treatment includes the immediate movement to a lower altitude. Prophylaxis has been accomplished successfully with the use of acetazolamide (Diamox).
(27 Sep 1997)
alzheimer disease A degenerative organic mental disease characterised by progressive brain deterioration and dementia. The disease was originally described as dementia, presenile occurring in persons under the age of 65 (as opposed to dementia, senile with onset at or after 65); however, onset may occur at any age. There is no pathophysiological nor clinical distinction between the two stages of onset of alzheimer's. Women appear to be affected twice as frequently as men. It is characterised pathologically by the triad of senile plaques, neurofibrillary tangles, and neuropil threads.
(12 Dec 1998)
Alzheimer's disease <disease> A progressive, neurodegenerative disease characterised by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.
The cause of nerve cell death is unknown but the cells are recognised by the appearance of unusual helical protein filaments in the nerve cells (neurofibrillary tangles) and by degeneration in cortical regions of brain, especially frontal and temporal lobes.
Alzheimer's disease is the most common cause of dementia.
(22 May 1997)
anaemia of chronic disease <disease> A form of anaemia which develops as the result of a long-term infection or illness. Chronic diseases can interfere with red blood cell production in addition to shortening red blood cell life span in the body.
Symptoms are largely due to the underlying disease. Haemoglobin and haematocrit are generally low. Iron studies may be low to normal. Red blood cell indices may usually normal.
(27 Sep 1997)
anarthritic rheumatoid disease Rheumatoid disease without arthritis.
(05 Mar 2000)
Anders' disease <disease> A disease accompanied by painful localised fatty swellings and by various nerve lesions. It is usually seen in women and may cause death from pulmonary complications.
(12 Dec 1998)
Andersen's disease Familial cirrhosis of the liver with storage of abnormal glycogen; glycogenosis due to deficiency of 1,4-alpha-glucan branching enzyme, resulting in accumulation of abnormal glycogen with long inner and outer chains in liver, kidney, muscle, and other tissues.
Synonym: Andersen's disease.
(05 Mar 2000)
antibody deficiency disease <syndrome> Any of a group of disorders associated with a defective antibody production due to defects in the B-type lymphocyte system or in T-type lymphocytes; chief manifestation is an increased susceptibility to infection by various microorganisms.
See: agammaglobulinaemia, hypogammaglobulinaemia, immunodeficiency.
Synonym: antibody deficiency disease.
(05 Mar 2000)
anti-glomerular basement membrane disease Glomerulonephritis, usually of a generalised proliferative crescent-forming histologic type with a rapidly progressive course, marked by circulating anti-gbm antibodies and linear deposits of immunoglobulin and complement along the glomerular basement membrane. When associated with pulmonary haemorrhage the condition is called goodpasture syndrome.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á